English
Specials
My Feed
Moneycontrol PRO
you are here:

Biogen

SYMBOL:BIIB|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
1
1
0
0
.
2
2
4
4
1
1
2.07 (1.48%)

As on 23 May, 2025 | 01:29 IST

Day Range
125.35
130.07
LH
52 Week Range
110.27
237.98
LH
Advance Chart
Open126.64
Previous Close126.97
Beta0.33
High130.07
Low125.35
TTM EPS See historical trend   15.82(+3.06% YoY)
52 Week High237.98
52 Week Low110.27
TTM PE See historical trend    7.99(Low PE)
Mkt. Cap ($ Billion)18.41
Dividend Yield--

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Bullish
See Details  
Historical Rating  
Moving AveragesBearish
Technical IndicatorsBullish
Moving Averages CrossoversNeutral

Pivot levels

TypeR1R2R3PPS1S2S3
Classic129.13 131.29 132.63127.78 125.62 124.28 122.12
Fibonacci129.12 129.95 131.29127.78 126.44 125.62 124.28
Camarilla127.29 127.61 127.93127.78 126.65 126.33 126.01

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5127.77
10124.86
20122.32
50126.78
100135.59
200159.44

Returns

Price Performance
1 Week2.30%
1 Month6.28%
3 Months
-10.26%
YTD
-17.34%
1 Year
-43.86%
3 Years
-36.72%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly732.30-0.25695.17123.705.920.96746.56/0.00-13.33Neutral
AbbVie207.90-0.08366.9517.4411.924.39210.41/0.007.73Bearish
Merck83.22-1.01211.1726.933.092.5385.48/0.000.24Bearish
Amgen313.690.42163.2417.4917.423.52329.72/215.32-1.81Bearish
Gilead Sciences112.54-1.21140.2316.106.993.89115.22/0.008.07Bearish
+ See More

Market news

Wall Street indexes end lower as jobs data fuels economic worries

September 6, 2025 10:13 AM
Show More

About the company

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company's marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions; GAZYVA indicated for the treatment of CLL and follicular lymphoma; OCREVUS for the treatment of primary progressive MS (PPMS) and relapsing MS (RMS), and other anti-CD20 therapies. The Company's pipeline includes BIIB074; BAN2401; BIIB061; BIIB067, BIIB124, BIIB074, BIIB118 and TMS-007.